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Fibroid is the most common neoplasm of the uterus in
the female pelvis during reproductive age. It is usually
the major problem and the reason for visiting a gyne-
cologist. It is nearly impossible to determine their true
incidence accurately, although the frequently quoted
incidence of 50% found at postmortem examinations
seems reasonable [1]. Uterine fibroid is a benign tumor
composed mainly of smooth muscle cells but contain-
ing varying amount of fibrous connective tissue. The
diagnosis is often easily confirmed noninvasively by 
ultrasonography, and the accuracy and sensitivity is
high especially when the uterus is less than 10 weeks’
size. However, localization of fibroids in a larger uterus
or when there are many tumors is limited [2]. The
characteristics of fibroids are commonly well-defined, 
concentric, solid, and hypoechoic.
The most common degeneration of fibroids is hya-
line change. These may become liquefied and form cys-
tic cavities filled with clear liquid or gelatinous material.
Sometimes, the cystic change would be great or with
multiple thin septa. Such variable appearances would
mislead the clinicians in making an entirely different di-
agnosis. We report a uterine fibroid with cystic degen-
eration and hemorrhagic infarction mimicking ovarian
malignancy.
A 55-year-old woman, gravida 6, para 4, had lower
abdominal fullness for about 3 months. She also com-
plained of progressive urinary frequency. She denied
having abdominal pain, nausea, vomiting or abnormal
uterine bleeding. There had been no change in bowel
movements. Furthermore, menopause had occurred
one year previously, and she denied receiving hormone
replacement therapy or Chinese herbs. She first presented
at a local clinic, where an ovarian mass was palpated and
she was referred for further management.
Pelvic-vaginal examination showed an enlarged pel-
vic mass of about 20 weeks’ gestational size. Trans-
abdominal ultrasonographic study revealed a huge
pelvic mass measuring 20 cm with multiple thick septa
and soft tissue components over the dependent part
(Figure 1). There was no obvious ascites. An abdomino-
pelvic computed tomography (CT) study displayed a
huge pelvic mass, measuring 12×29×32 cm in size,
which contained fluid and soft tissue components
(Figure 2). Her serum level of CA-125 was 120 U/mL.
Ovarian malignancy was highly suspected. She had 
a history of right thyroid papillary adenocarcinoma and
had received a total thyroidectomy and radical lymph
node dissection 11 years previously. She was regularly
followed up at the outpatient department, and no 
evidence of disease recurrence had been noted.
After complete study, an exploratory laparotomy
with midline longitudinal incision was performed. We
found multiple myomas in the uterus and one huge
mass with a stalk of about 2 cm connected to the uter-
ine fundal area. The capsule surrounding the mass was
intact with irregular contours, and there were complex
cystic and soft tissue components in the mass. The
cystic portion was about 30×30×15 cm, and about
8,000 mL of old bloody fluid was aspirated from the
tumor. The soft tissue portion measured about 12×
10×10 cm. The cut tumor surface revealed multiple
septa with smoothed out surface and hemorrhagic fluid
content. Bilateral adnexa were normal in size and con-
tour (Figure 3). A frozen section of the specimen showed
leiomyoma with hemorrhagic cyst. Abdominal total hys-
terectomy and bilateral salpingo-oophorectomy were
consequently performed. The patient stood the pro-
cedure well and was discharged 6 days after surgery.
Permanent microscopic examination revealed leiomyoma
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with cystic tumors containing extensive degeneration and
hemorrhage with infarcts (Figure 4). Her serum level of
CA-125 dropped to 16.3 U/mL 8 months later.
Uterine leiomyoma is the most common gynecologic
neoplasm in women of reproductive age. It is a major
reason for visits to the gynecologists. It is a kind of over-
growth of smooth muscle or connective tissue of the
uterus and is benign in nature. The precise etiology of
leiomyoma is unclear. Estrogen can stimulate the growth
of leiomyoma, so growths may be noticed after menar-
che, with progression during pregnancy and shrinkage
after menopause. The regrowth is observed after starting
hormone therapy. Most commonly, degeneration occurs
when the fibroid outgrows its blood supply [3]. The
result is various types of degeneration: hyaline or myx-
oid degeneration, calcification, cystic degeneration,
and red degeneration (hemorrhagic infarction) [4].
The degenerations accompany changes of hormonal
status. The most common type of degeneration is focal
or generalized hyalinization [5]. Hyalinization occurs in
more than 60% of fibroids and is usually extensive [6–8].
At the microscopic level, hyalinization begins in the stro-
mal component that separates the smooth muscle cells
and then progresses on to the extensive replacement of
smooth muscle cells [9]. The combination of hyalin-
ization with liquefaction may result in cystic degenera-
tion because of a decreased blood supply, so we can
regard cystic degeneration as a late stage of hyaline
degeneration. Cystic degeneration is observed in about
4% of leiomyomas [4]. Large or small cystic spaces
develop in the edematous and acellular center [6–8].
Red or carneous degeneration results from massive hem-
orrhagic infarction of a leiomyoma due to obstruction
of drainage veins at the periphery of the lesion [5].
Magnetic resonance (MR) imaging is the most ac-
curate technique to detect and localize leiomyomas.
Degenerating leiomyomas have variable appearances
on T2-weighted images and contrast-enhanced images
[10]. However, ultrasonography is the best choice for
gynecologists to detect and evaluate pelvic lesions, be-
cause it is simple and noninvasive. Under ultrasonic imag-
ing, a uterine myoma frequently appears as a concentric,
solid, hypoechoic mass. There are various changes in
their degree of echogenicity, depending on the amount
of fibrous tissue, calcification or necrosis present. Gen-
erally, the ultrasonic appearance of uterine fibroids is
typical, making diagnosis uncomplicated. Unfortunately,
irregular areas of cystic degeneration can appear as 
a bizarre mixture of cysts, multiple thin septa, and solid
components with variable echogenicity [11]. These ul-
trasonic characteristics of leiomyomas undergoing cystic
degeneration can mislead diagnosing physicians in an
entirely different direction, as it is quite challenging to
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Figure 1. Transabdominal ultrasonography. (A) Several thick and irregular septa within the mass. (B) One soft tissue component
covering the dependent part of the mass. No obvious ascites is present.
Figure 2. A huge pelvic mass measuring 12×29×32 cm in
size containing fluid and soft tissue components. No ascites
is noted.
distinguish a benign leiomyoma from a malignant one.
Furthermore, by using ultrasonography, the nature of
the lesion is at least partially defined by viewing the
continuity of the mass with the uterus [12], but this may
be difficult with some patients, especially those with 
a huge mass. Our patient’s lesion was the largest cystic
leiomyoma of the uterus we could find in the literature.
Careful inspection of the walls of a mass and looking
for its pedicle may provide an opportunity to discover
its anatomic source. In reviewing past case reports,
subserosal and submucosal leiomyomas may also be
considered as ovarian tumors, endometrial hyperplasia
or variable gestational abnormalities, including ectopic
pregnancy, blighted ovum or hydatidiform mole [3,12].
However, we can easily distinguish gestational abnormal-
ities from other possibilities by serum levels of beta-hCG.
CT scanning plays only a limited role in the diag-
nosis of uterine leiomyoma. Unless there is necrosis or
calcification, it is difficult to distinguish leiomyoma from
normal myometrium tissue. Compared with CT scans,
MR imaging plays a more important role in differenti-
ating the anatomy of the uterus and ovaries. Each type
of secondary change within leiomyomas shows distinc-
tive MR findings through heterogeneous signal inten-
sity on T2-weighted images, although clear distinctions
between each type of degeneration cannot be made
with this modality [13]. Additionally, color Doppler
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Figure 3. (A) There were two parts within the mass.
The upper portion was cystic with hemorrhagic lesions,
and the lower portion appeared solid in the ultrasono-
graphic image. Exploring the solid part revealed it to be
compatible with leiomyoma. The frozen section report
showed leiomyoma with cystic degeneration and hemor-
rhagic infarction. (B) Hemorrhagic necrotic tissue within
the cystic lesion. (C) Anatomically normal uterus and
bilateral adnexa after myomectomy.
Figure 4. Photomicrograph of the cystic leiomyoma reveals
several cystic cavities. The cystic tumors contain extensive
degeneration and hemorrhage with infarcts. There are resid-
ual areas of smooth muscle bundles present in the wall
(hematoxylin and eosin, ×20).
examination can identify the vascular supply and often
visualize a mass defect that might not be detectable
with grayscale images [14]. Based on economic con-
siderations, color Doppler examination may be prefer-
able to CT and MR imaging. Besides imaging studies,
clinical symptoms and signs also play an important
part in making a differential diagnosis.
Besides malignancy, elevated CA-125 levels have
been linked to various benign gynecologic and non-
gynecologic diseases, including endometriosis, leiomy-
oma, pelvic inflammatory disease and cirrhosis [15]. 
A MEDLINE search of the English medical literature
from January 1966 to December 2006 failed to iden-
tify any reports of degenerative change of uterine fibroid
and elevated level of serum CA-125, apart from Pseudo-
Meigs syndrome. Ours is the only case of elevated 
levels of serum CA-125 with degenerative changes in 
a uterine fibroid, and it does not match the criteria for
Pseudo-Meigs syndrome. Ghamande et al presented 
a case report of parasitic fibroid with a high level of
CA-125 [16]. The sustained fall and normalization 
of CA-125 levels after myomectomy described by
Ghamande et al is just like that of our case. CA-125
has been shown by immunohistochemistry to be lo-
calized in the epithelium of the fallopian tube, endo-
metrium, cervix, and the mesothelial cells of pleura,
pericardium and peritoneum [17]. Ghamande et al
supposed that the most likely source of elevated CA-
125 seemed to be the peritoneum responding to per-
sistent stimulation by the large parasitic fibroid [16].
Unfortunately, the absence of staining of the fibroid
with CA-125 by immunohistochemistry did not support
the theory.
In conclusion, to the best of our knowledge, this is
the largest cystic degeneration combined with hemor-
rhagic infarction in a uterine fibroid reported in the lit-
erature. Transabdominal and transvaginal sonography
are the primary and most cost-effective imaging modal-
ities for the detection of leiomyomas [18]. Degenerative
changes further result in a heterogeneous or unusual
appearance that contributes to diagnostic confusion
[19]. Color Doppler imaging can expand the information
available in our clinic. MR imaging is the most accu-
rate technique for differentiating degenerative fibroids
prior to surgical intervention.
References
1. Breech LL, Rock JA. Leiomyomata uteri and myomectomy.
In: Rock JA, Jones HW III, eds. Te Linde’s Operative Gynecology,
9th edition. Philadelphia: Lippincott Williams & Wilkins,
2003:755.
2. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F.
Accuracy of magnetic resonance imaging and transvaginal
ultrasonography in the diagnosis, mapping, and measure-
ment of uterine myomas. Am J Obstet Gynecol 2002;186:
409–15.
3. Cohen JR, Luxman D, Sagi J, Jossiphov J, David MP.
Ultrasonic “honeycomb” appearance of uterine submucous
fibroids undergoing cystic degeneration. J Clin Ultrasound
1995;23:293–6.
4. Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA,
Tureck RW. Uterine leiomyomas: histopathologic features,
MR imaging findings, differential diagnosis, and treatment.
Radiographics 1999;19:1179–97.
5. Ueda H, Togashi K, Konishi I, et al. Unusual appearances 
of uterine leiomyomas: MR imaging findings and their
histopathologic backgrounds. Radiographics 1999;19(Suppl):
S131–45.
6. Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus.
In: Kurman RJ, ed. Blanstein’s Pathology of the Female Genital
Tract. New York: Springer-Verlag, 1994:487–98.
7. Woodruff JD, Parmley TI. Atlas of Gynecologic Pathology.
Philadelphia: Lippincott-Raven, 1998.
8. Rosai J. Ackerman’s Surgical Pathology, 8th edition. St Louis:
Mosby-Year Book, 1996:1429–33.
9. Silverberg SG, Kurman RJ. Smooth muscle and other mes-
enchymal tumors. In: Rosai J, ed. Tumors of the Uterine Corpus
and Gestational Trophoblastic Disease. Washington, DC: Armed
Forced Institute of Pathology, 1992:113–30.
10. Okizuka H, Sugimura K, Takemori M, Obayashi C, Kitao M,
Ishida T. MR detection of degenerating uterine leiomyomas.
J Comput Assist Tomogr 1993;17:760–6.
11. Reddy NM, Jain KA, Gerscovich EO. A degenerating cystic
uterine fibroid mimicking an endometrioma on sonogra-
phy. J Ultrasound Med 2003;22:973–6.
12. Beaumont B. Cystic degeneration of a fibroid mimicking
blighted ovum. Radiogr Today 1989;55:24–5.
13. Ha HK, Jee MK, Lee HJ, Choe BY, Park JS, Lee JM, Nam-
Koong SE. MR imaging analysis of heterogeneous leiomy-
omas of the uterus. Front Biosci 1997;2:f4–12.
14. Yarwood RL, Arroyo E. Cystic degeneration of a uterine
leiomyoma masquerading as a postmenopausal ovarian
cyst. J Reprod Med 1999;44:649–52.
15. Dunn JS Jr, Anderson CD, Method MW, Brost BC. Hydropic
degenerating leiomyoma presenting as pseudo-Meigs syn-
drome with elevated CA 125. Obstet Gynecol 1998;92:648–9.
16. Ghamande SA, Eleonu B, Hamid AM. High levels of CA-
125 in a case of a parasitic leiomyoma presenting as an
abdominal mass. Gynecol Oncol 1996;61:297–8.
17. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC,
Colvin RB. Tissue distribution of a coelomic-epithelium-
related antigen recognized by the monoclonal antibody
OC125. Int J Gynecol Pathol 1983;2:275–85.
18. Low SC, Chong CL. A case of cystic leiomyoma mimicking
an ovarian malignancy. Ann Acad Med Singapore 2004;33:
371–4.
19. Baltarowich OH, Kurtz AB, Pennell RG, Needleman L,
Vilaro MM, Goldberg BB. Pitfalls in the sonographic diag-
nosis of uterine fibroids. AJR Am J Roentgenol 1998;151:
725–8.
Taiwan J Obstet Gynecol • December 2007 • Vol 46 • No 4434
M.S. Jao, et al
